Abstract:BackgroundUsing interpretable machine learning, we sought to define the immune microenvironment subtypes and distinctive genes in AD. MethodsssGSEA, LASSO regression, and WGCNA algorithms were used to evaluate immune state in AD patients. To predict the fate of AD and identify distinctive genes, six machine learning algorithms were developed. The output of machine learning models was interpreted using the SHAP and LIME algorithms. For external validation, four separate GEO databases were used. We estimated the subgroups of the immunological microenvironment using unsupervised clustering. Further research was done on the variations in immunological microenvironment, enhanced functions and pathways, and therapeutic medicines between these subtypes. Finally, the expression of characteristic genes was verified using the AlzData and pan-cancer databases and RT-PCR analysis. ResultsIt was determined that AD is connected to changes in the immunological microenvironment. WGCNA revealed 31 potential immune genes, of which the greenyellow and blue modules were shown to be most associated with infiltrated immune cells. In the testing set, the XGBoost algorithm had the best performance with an AUC of 0.86 and a P-R value of 0.83. Following the screening of the testing set by machine learning algorithms and the verification of independent datasets, five genes (CXCR4, PPP3R1, HSP90AB1, CXCL10, and S100A12) that were closely associated with AD pathological biomarkers and allowed for the accurate prediction of AD progression were found to be immune microenvironment-related genes. The feature gene-based nomogram may provide clinical advantages to patients. Two immune microenvironment subgroups for AD patients were identified, subtype2 was linked to a metabolic phenotype, subtype1 belonged to the immune-active kind. MK-866 and arachidonyltrifluoromethane were identified as the top treatment agents for subtypes 1 and 2, respectively. These five distinguishing genes were found to be intimately linked to the development of the disease, according to the Alzdata database, pan-cancer research, and RT-PCR analysis. ConclusionThe hub genes associated with the immune microenvironment that are most strongly associated with the progression of pathology in AD are CXCR4, PPP3R1, HSP90AB1, CXCL10, and S100A12. The hypothesized molecular subgroups might offer novel perceptions for individualized AD treatment.

Identification of disulfidptosis-related genes and subgroups in Alzheimer's disease

Machine learning identification and immune infiltration of disulfidptosis‐related Alzheimer's disease molecular subtypes

Identifying Shared Diagnostic Genes and Mechanisms in Vascular Dementia and Alzheimer's Disease Via Bioinformatics and Machine Learning

Unveiling disulfidptosis-related biomarkers and predicting drugs in Alzheimer's disease

Exploring the Key Genes and Identification of Potential Diagnosis Biomarkers in Alzheimer’s Disease Using Bioinformatics Analysis

Identification of Diagnostic Biomarkers in Alzheimer's Disease by Integrated Bioinformatic Analysis and Machine Learning Strategies.

Identification of immunogenic cell death-related genes involved in Alzheimer's disease

Identification of Autophagy-Related Biomarkers and Diagnostic Model in Alzheimer's Disease

Identification of Endoplasmic Reticulum Stress-Associated Genes and Subtypes for Prediction of Alzheimer’s Disease Based on Interpretable Machine Learning

Identification of Immune Cells and Key Genes associated with Alzheimer's Disease

Identification of novel hub genes for Alzheimer's disease associated with the hippocampus using WGCNA and differential gene analysis

Discovery and validation of Ferroptosis-related molecular patterns and immune characteristics in Alzheimer's disease

Identification of Blood-Based Glycolysis Gene Associated with Alzheimer's Disease by Integrated Bioinformatics Analysis

Alzheimer's Disease and Aging Association: Identification and Validation of Related Genes

Identification of cuproptosis-related genes in Alzheimer's disease based on bioinformatic analysis

Identification of immune microenvironment subtypes and signature genes for Alzheimer's disease diagnosis and risk prediction based on explainable machine learning

Integrated Bioinformatic Analysis and Validation Identifies Immune Microenvironment-Related Potential Biomarkers in Alzheimer’s Disease

Alzheimer’s Disease and Aging Association: Identification and Validation of Related Genes

Identifying the Role of Oligodendrocyte Genes in the Diagnosis of Alzheimer's Disease Through Machine Learning and Bioinformatics Analysis.

[Identification of Potential Hub Genes of Alzheimer's Disease by Weighted Gene Co-Expression Network Analysis].

Identification of novel risk genes for Alzheimer's disease by integrating genetics from hippocampus